Pan-CoV

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

BROAD-SPECTRUM MULTI-ANTIGEN PAN-CORONAVIRUS VACCINE
US 2024269266 A1申请人: UNIV CALIFORNIA优先权: 2024
US
4 件公开
PAN-SPECIFIC CORONA VIRUS BINDERS
US 2024228596 A1申请人: VIB VZW优先权: 2021
CN
US
2 件公开
ANTISENSE OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS AGAINST SARS COV-2
EP 4763985 A1申请人: CENTRE NAT RECH SCIENT优先权: 2024
EP
WO
2 件公开
MULTI-EPITOPE PAN-CORONAVIRUS VACCINE COMPOSITIONS
- WO 2021211749 A1
  申请人: UNIV CALIFORNIA优先权: 2020
  WO
- US 2023146932 A1
  申请人: UNIV CALIFORNIA优先权: 2022
  US
PAN-SPECIFIC SARS-COV-2 ANTIBODIES AND USES THEREOF
WO 2023111796 A1申请人: NAT RES COUNCIL CANADA优先权: 2021
WO
PAN-CHEMOKINE ANTAGONISTS FOR USE IN TREATING CANCER AND IMMUNE DISORDERS
US 20250206754 A1申请人: MICAR INNOVATION LTD优先权: 2022
US
TREATMENT OF DISEASES CAUSED BY RNA VIRUSES
US 20250288547 A1申请人: AMERIMMUNE LLC优先权: 2022
US
Treatment for diseases caused by RNA virus SARS-CoV-2
US 12377127 B2申请人: AMERIMMUNE LLC优先权: 2023
US
PREFUSION-STABILIZED SARS-COV-2 SPIKE S2 SUBUNIT AS ANTIGEN FOR BROAD PAN-CORONAVIRUS VACCINES
WO 2025106792 A1申请人: LA JOLLA INST FOR IMMUNOLOGY优先权: 2023
WO
COVALENT INHIBITION OF SARS-COV-2 RNA METHYLATION FOR TREATMENT OF PAN-CORONAVIRAL INFECTIONS
WO 2025207791 A1申请人: UNIV TEXAS优先权: 2024
WO